静脉动脉移除终点:超越非诱导性
Pasquale Santangeli1, Koji Higuchi1, Jakub Sroubek1
1Section of Cardiac Pacing and Electrophysiology, Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio, USA.
JACC. Clinical electrophysiology
|February 22, 2024
概括
编程电刺激 (PES) 用于腹腔动脉冲动 (VT) 移除有局限性. 除了VT非诱导性之外,还需要新的终点,以更好地预测与痕相关的VT的长期结果.
科学领域:
- 心脏病学 心脏病学
- 电子生理学 电子生理学
- 医疗器械 医疗器械
背景情况:
- 导管切除用于心脏结构性疾病中的腹腔动心 (VT).
- 编程电刺激 (PES) 传统上评估急性成功并预测结果.
- 通过PES的非诱导性具有低于最佳的长期VT自由预测和限制.
研究的目的:
- 批判性地评估与痕相关的静脉瘤的导管切除现有和新手术终点.
- 评估各种废弃技术中不同终点的优点和局限性.
- 解决需要改进超越PES非诱导性的终点的需求.
主要方法:
- 审查和对现有关于VT废除程序终点的文献进行批判性评估.
- 编程电刺激 (PES) 的局限性分析.
- 基于基质的剥离方法对终点的评估.
主要成果:
- 通过PES验证了非诱导性,但对于长期的VT自由性而言,其预测性能不足于最佳.
- PES受到抗失常药物,麻醉和协议变化的限制.
- 基于基质的剥离需要除了PES非诱导性之外的额外终点.
结论:
- 目前对VT废除的终点,特别是PES非诱导性,需要重新评估.
- 新的终点对于优化与痕相关的静脉瘤导管切除策略至关重要.
- 需要进一步的研究来确定优越的程序终点.
更多相关视频
12:45Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
10.5K
10:46Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology
Published on: May 26, 2015
13.3K
相关概念视频
Disturbances in Heart Rhythm
956
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
956
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
832
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
832
